EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reframing chronic pain through the microbiota-gut-brain axis: from mechanisms to clinical meaning

Kakhaber Chelidze, Matteo Luigi Giuseppe Leoni, Dariusz Myrcik, Y Van Tran, Phong Van Pham, Giustino Varrassi

Advancements in Health Research · 04.06.2026 · 3

DOI: 10.4081/ahr.2026.139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advancements in Health Research, online erschienen am 04.06.2026. Verfasst von Kakhaber Chelidze und 5 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain is increasingly accepted in the scientific literature as a multidimensional disorder shaped by dynamic interactions between peripheral tissues, the nervous system, and immune pathways, rather than as a direct consequence of structural pathology alone. Within this evolving framework, the microbiota-gut-brain axis has emerged as a compelling systems-level model capable of integrating nociceptive, neuropathic, and nociplastic mechanisms into a unified biological context. This narrative review reframes chronic pain through this axis, synthesizing current evidence on how gut microbial ecosystems influence pain processing via interconnected epithelial, immune, neural, and neuroendocrine pathways. We examine key mechanistic domains, including intestinal barrier integrity, microbial-derived metabolites such as short-chain fatty acids and tryptophan products, vagal and autonomic signaling, hypothalamic-pituitary-adrenal axis modulation, and neuroimmune reprogramming involving glial and peripheral immune cells. These pathways converge to modulate nociceptor sensitivity, central sensitization, and symptom clusters frequently accompanying chronic pain, including fatigue, mood disturbance, and bowel dysfunction. Evidence from human observational studies, translational experiments, Mendelian randomization analyses, and early interventional trials suggest that microbiota-related alterations are not merely epiphenomenal but may contribute to pain vulnerability and persistence across selected phenotypes, with the most consistent and clinically supported evidence observed in visceral pain disorders such as irritable bowel syndrome, while evidence in other conditions, including fibromyalgia, neuropathic pain, and cancer-related pain, remains more heterogeneous or predominantly translational. Despite growing mechanistic plausibility, clinical translation remains constrained by heterogeneity in study design, inconsistent microbial signatures, and limited high-quality interventional data. Accordingly, we propose a pragmatic interpretation for clinicians, emphasizing microbiome-informed adjunctive strategies within multimodal pain management rather than standalone therapeutic approaches. The microbiota-gut-brain axis should therefore be viewed not as a discrete target, but as a regulatory network that refines our understanding of chronic pain complexity and opens avenues for personalized, systems-based care.

Zitieren

APA

Chelidze, K., Leoni, M. L. G., Myrcik, D., Tran, Y. V., Pham, P. V., & Varrassi, G. (2026). Reframing chronic pain through the microbiota-gut-brain axis: from mechanisms to clinical meaning. Advancements in Health Research, 3. https://doi.org/10.4081/ahr.2026.139

Vancouver

Chelidze K, Leoni MLG, Myrcik D, Tran YV, Pham PV, Varrassi G. Reframing chronic pain through the microbiota-gut-brain axis: from mechanisms to clinical meaning. Advancements in Health Research. 2026;3. doi:10.4081/ahr.2026.139

BibTeX
@article{Chelidze2026,
  author = {Chelidze, Kakhaber and Leoni, Matteo Luigi Giuseppe and Myrcik, Dariusz and Tran, Y Van and Pham, Phong Van and Varrassi, Giustino},
  title = {Reframing chronic pain through the microbiota-gut-brain axis: from mechanisms to clinical meaning},
  journal = {Advancements in Health Research},
  year = {2026},
  volume = {3},
  doi = {10.4081/ahr.2026.139}
}
Kostenlos starten →